Mumbai, Sept. 26 -- Jyoti Structures will hold a meeting of the Board of Directors of the Company on 30 September 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, Sept. 26 -- Taaza International will hold a meeting of the Board of Directors of the Company on 26 September 2025. Published by HT Digital Content Services with permission from Capital Market... Read More
Mumbai, Sept. 26 -- Checkpoint Trends announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 October 2025. Published by HT Digital Content Services with permission f... Read More
Mumbai, Sept. 26 -- The Nifty Pharma index slumps 1.64% to 21,617.25. The index is down 4.71% in five consecutive sessions. Natco Pharma (down 3.42%) and Laurus Labs (down 3.32%) leading the fall, fo... Read More
Mumbai, Sept. 26 -- Cyber Media (India) will hold a meeting of the Board of Directors of the Company on 30 September 2025. Published by HT Digital Content Services with permission from Capital Market... Read More
Mumbai, Sept. 26 -- Latent View Analytics will hold a meeting of the Board of Directors of the Company on 24 October 2025. Published by HT Digital Content Services with permission from Capital Market... Read More
Mumbai, Sept. 26 -- Mphasis will hold a meeting of the Board of Directors of the Company on 30 October 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, Sept. 26 -- ADC India Communications will hold a meeting of the Board of Directors of the Company on 11 November 2025. Published by HT Digital Content Services with permission from Capital Ma... Read More
Mumbai, Sept. 26 -- This win marks a major addition to the company's growing portfolio in government and defense service engagements. According to the official notification, the contract is valued at... Read More
Mumbai, Sept. 26 -- Domestic equity indices opened lower after President Trump announced a 100% tariff on branded drug imports starting from 1 Oct 2025, pressuring pharma stocks despite generics being... Read More